Fact: According to the U.S. Food and Drug Administration, African-Americans make up about 5 percent of clinical trial participants and Latino Americans constitute 1 percent.African-Americans are diagnosed with more advanced cancer, and death rates are higher. One way to help combat the issue is to have more people of color participate in clinical trials. But overcoming historical stigma is a major concern for minority populations and is likely one of the most common factors driving the low participation numbers.
